References
Pacini F, Basolo F, Bellantone R et al (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Investig 41(7):849–876. https://doi.org/10.1007/s40618-018-0884-2
Yang SP, Bach AM, Tuttle RM, Fish SA (2015) Serial neck ultrasound is more likely to identify false positive abnormalities than clinically significant disease in low risk papillary thyroid cancer patients. Endocr Pract 21:1372–1379
Verburg FA, Mäder U, Giovanella L, Luster M, Reiners C (2018) Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and 131I ablation. Thyroid 28(6):722–728. https://doi.org/10.1089/thy.2017.0352
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
A written informed consent was obtained from each patient.
Rights and permissions
About this article
Cite this article
Campennì, A., Tulchinsky, M. Should the use of neck-ultrasonography be reduced during the follow-up of differentiated thyroid cancer patients with undetectable or low (i.e., < 1 µg/L) thyroglobulin levels and negative thyroglobulin antibody?. J Endocrinol Invest 42, 105–106 (2019). https://doi.org/10.1007/s40618-018-0957-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0957-2